These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1466987)

  • 21. Long-lasting protection by live attenuated simian immunodeficiency virus in cynomolgus monkeys: no detection of reactivation after stimulation with a recall antigen.
    Sernicola L; Corrias F; Koanga-Mogtomo ML; Baroncelli S; Di Fabio S; Maggiorella MT; Belli R; Michelini Z; Macchia I; Cesolini A; Cioè L; Verani P; Titti F
    Virology; 1999 Apr; 256(2):291-302. PubMed ID: 10191194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of protection from homologous cell-free vs cell-associated SIV challenge afforded by inactivated whole SIV vaccines.
    Heeney JL; de Vries P; Dubbes R; Koornstra W; Niphuis H; ten Haaft P; Boes J; Dings ME; Morein B; Osterhaus AD
    J Med Primatol; 1992; 21(2-3):126-30. PubMed ID: 1433263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccination of macaques with SIV conserved envelope peptides suppressed infection and prevented disease progression and transmission.
    Shafferman A; Lewis MG; McCutchan FE; Benveniste RE; Jahrling PB; Hickman RL; Lai CY; Burke DS; Eddy GA
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1483-7. PubMed ID: 1281660
    [No Abstract]   [Full Text] [Related]  

  • 24. Efficacy of live-attenuated and whole-inactivated simian immunodeficiency virus vaccines against vaginal challenge with virulent SIV.
    Marthas ML; Miller CJ; Sutjipto S; Higgins J; Torten J; Lohman BL; Unger RE; Ramos RA; Kiyono H; McGhee JR
    J Med Primatol; 1992; 21(2-3):99-107. PubMed ID: 1433273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunization of Macaca fascicularis with inactivated SIV preparations: challenge with human- or monkey-derived SIV and the effects of a longer immunization schedule.
    Titti F; Koanga Mogtomo ML; Borsetti A; Geraci A; Sernicola L; Panzini G; Turillazzi GP; Baroncelli S; Giovannetti A; Zamarchi R
    J Med Primatol; 1993; 22(2-3):110-8. PubMed ID: 8411103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protection against human immunodeficiency virus type 2 and simian immunodeficiency virus in macaques vaccinated against human immunodeficiency virus type 2.
    Biberfeld G; Thorstensson R; Putkonen P
    AIDS Res Hum Retroviruses; 1996 Mar; 12(5):443-6. PubMed ID: 8882330
    [No Abstract]   [Full Text] [Related]  

  • 27. AIDS vaccine developments.
    Le Grand R; Vaslin B; Vogt G; Roques P; Humbert M; Dormont D
    Nature; 1992 Feb; 355(6362):684. PubMed ID: 1741053
    [No Abstract]   [Full Text] [Related]  

  • 28. Simian immunodeficiency virus-specific cytotoxic T lymphocytes and protection against challenge in rhesus macaques immunized with a live attenuated simian immunodeficiency virus vaccine.
    Nixon DF; Donahoe SM; Kakimoto WM; Samuel RV; Metzner KJ; Gettie A; Hanke T; Marx PA; Connor RI
    Virology; 2000 Jan; 266(1):203-10. PubMed ID: 10612675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of protective efficacy of recombinant subunit vaccines against simian immunodeficiency virus infection of macaques.
    Hu SL; Abrams K; Misher L; Stallard V; Moran P; Zarling JM; Langlois AJ; Kuller L; Morton WR; Benveniste RE
    J Med Primatol; 1992; 21(2-3):119-25. PubMed ID: 1433262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV-1 vaccines based on replication-competent Tiantan vaccinia protected Chinese rhesus macaques from simian HIV infection.
    Liu Q; Li Y; Luo Z; Yang G; Liu Y; Liu Y; Sun M; Dai J; Li Q; Qin C; Shao Y
    AIDS; 2015 Mar; 29(6):649-58. PubMed ID: 25849828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A formalin inactivated whole SIV vaccine and a glycoprotein-enriched subunit vaccine confers protection against experimental challenge with pathogenic live SIV in rhesus monkeys.
    Murphey-Corb M; Martin LN; Davison-Fairburn B; Montelaro RC; Miller M; West M; Ohkawa S; Baskin GB; Zhang JY; Putney S
    Dev Biol Stand; 1990; 72():273-85. PubMed ID: 2282987
    [No Abstract]   [Full Text] [Related]  

  • 32. Protection from pathogenic SIVmac challenge following short-term infection with a nef-deficient attenuated virus.
    Norley S; Beer B; Binninger-Schinzel D; Cosma C; Kurth R
    Virology; 1996 May; 219(1):195-205. PubMed ID: 8623530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inoculation of Macaca fascicularis with simian immunodeficiency virus, SIVmne immunologic, serologic, and pathologic changes.
    Kuller L; Morton WR; Benveniste RE; Tsai CC; Clark EA; Gale MJ; Hu SL; Thouless ME; Katze MG
    J Med Primatol; 1990; 19(3-4):367-80. PubMed ID: 2231689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Virus-specific helper T cell response of macaques immunized with inactivated whole SIV is not correlated with reactivity against cellular components of vaccine preparation.
    Dittmer U; Lüke W; Stahl-Hennig C; Hunsmann G; Voss G
    AIDS Res Hum Retroviruses; 1994 Apr; 10(4):329-30. PubMed ID: 8068411
    [No Abstract]   [Full Text] [Related]  

  • 35. Simian immunodeficiency virus-specific cytotoxic T lymphocytes in rhesus monkeys: characterization and vaccine induction.
    Letvin NL; Miller MD; Shen L; Chen ZW; Yasutomi Y
    Semin Immunol; 1993 Jun; 5(3):215-23. PubMed ID: 8394161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of humoral immune responses in rhesus macaques vaccinated with attenuated SIVmac239Deltanef and challenged with pathogenic SIVmac251.
    Freissmuth D; Hiltgartner A; Stahl-Hennig C; Fuchs D; Tenner-Racz K; Racz P; Uberla K; Strasak A; Dierich MP; Stoiber H; Falkensammer B
    J Med Primatol; 2010 Apr; 39(2):97-111. PubMed ID: 20015159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunization against HIV. Problems in developing a vaccine].
    Uhl D
    Med Monatsschr Pharm; 1988 Nov; 11(11):376-8. PubMed ID: 3059163
    [No Abstract]   [Full Text] [Related]  

  • 38. [Live attenuated viruses: a new strategy for vaccination against AIDS].
    Molina JM
    Pathol Biol (Paris); 1993 Jun; 41(6):513-4. PubMed ID: 8247628
    [No Abstract]   [Full Text] [Related]  

  • 39. Alternative interpretation of lymphocyte depletion studies using monoclonal antibodies in animals previously vaccinated with attenuated retroviral vaccines.
    Dittmer U; Hasenkrug KJ
    AIDS Res Hum Retroviruses; 1999 May; 15(8):785. PubMed ID: 10357475
    [No Abstract]   [Full Text] [Related]  

  • 40. Prevention of HIV-2 and SIVSM infection in cynomolgus monkeys by active or passive immunization.
    Biberfield G; Putkonen P; Thorstensson R; Norrby E
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1511-3. PubMed ID: 1466992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.